Newsletter/Booklets 7th Jul 2023

Market Access Barriers in The Pharmaceutical Sector in India’s Key Export Destinations

Authors

Parthsarathi JhaPartner | New Delhi | Noida
Sanjay NotaniPartner | Mumbai
Mitul KaushalConsultant | Delhi NCR
Harika BakarajuPrincipal Associate | Mumbai
Naghm GheiPrincipal Associate | Delhi NCR
Divyashree SuriSenior Associate | Delhi NCR

Latest Thought Leadership

international trades
Alerts & Updates 22nd May 2026

U.S. OFAC Enforcement – Adani Enterprise Limited

Read More
Newsletter/Booklets 22nd May 2026

Recent Developments in Direct & Indirect Tax

Read More
Alerts & Updates 22nd May 2026

Consent Manager under the DPDP Act: A New Institutional Layer for India’s Data Protection Regime

Read More
Investment Funds
Alerts & Updates 20th May 2026

Pledging of securities of Non-Discretionary Portfolio Management Services clients – Informal Guidance by SEBI

Read More

This report examines the regulatory environment of some of India’s key trading partners, with a view to identify existing and potential trade barriers in exporting pharmaceuticals in these markets.  This serves as a ready reckoner and comprehensive guide for the pharmaceutical industry.

Click here

Privacy Policy

As per the rules of the Bar Council of India, lawyers and law firms are not permitted to solicit work or advertise. By clicking on the "I Agree" button, you acknowledge and confirm that you are seeking information relating to Economic Laws Practice (ELP) of your own accord and there has been no advertisement, personal communication, solicitation, invitation or any other inducement of any sort whatsoever by or on behalf of ELP or any of its members to solicit any work through this website.